🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities! 🎄🌟 🎉
Lakeside signs $1.5 M sales agreement with China's Sinopharm Group Subsidiary
Pharma | News | 0 Comment | 18 Dec, 2024
Lakeside Holding, a US-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific&nb...Read more
Korea's SK Biopharmaceuticals eyes innovative small protein-based radiopharmaceuticals
Pharma | News | 0 Comment | 17 Dec, 2024
SK Biopharmaceuticals, a biotech company focusing on the research, development and commercialisation of treatments for d...Read more
Pharma | News | 0 Comment | 16 Dec, 2024
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-qu...Read more
Eisai Subsidiary inks €117 M deal for schizophrenia treatment in Japan and other Asian territories
Pharma | News | 0 Comment | 16 Dec, 2024
Newron Pharmaceuticals, a biopharmaceutical company focused on the development of novel therapies for patients with dise...Read more
Pharma | News | 0 Comment | 13 Dec, 2024
The National Pharmaceutical Regulatory Agency (NPRA) Malaysia has approved Boehringer Ingelheim's Spesolimab (marketed a...Read more
CU Medicine and CTTQ collaborate to strengthen pharma innovations in Hong Kong
Pharma | News | 0 Comment | 10 Dec, 2024
The Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine) has entered into a strategic partnership wi...Read more
Israel's Teva Pharma to divest business venture in Japan
Pharma | News | 0 Comment | 06 Dec, 2024
Israel-based Teva Pharmaceutical Industries has entered into an agreement with JKI, established by the fund managed and ...Read more
US-Taiwan partnership to advance manufacturing of Sjögren's Syndrome drug
Pharma | News | 0 Comment | 03 Dec, 2024
Ainos, Inc., an innovative healthcare company focused on advanced artificial intelligence (AI)-driven point-of-care test...Read more
Pharma | News | 0 Comment | 30 Nov, 2024
The University of Hong Kong (HKU), represented by Versitech Limited, has signed an agreement with China Merchants Group ...Read more
2025 Trends Buoying Boom Phase in APAC
Pharma | Analysis | By Ayesha Siddiqui | 0 Comment | 01 Dec, 2024
Antibody Drug Conjugates (ADCs) in Stoplight ADCs, touted as ‘magic bullets’ for targeted cancer ther...Read more
Pharma | News | 0 Comment | 27 Nov, 2024
A leading healthcare distribution company, Kingworld Medicines Group Limited, has officially started operations at the K...Read more
Zai Lab and Pfizer announce strategic collaboration for novel anti-bacterial drug XACDURO
Pharma | News | 0 Comment | 25 Nov, 2024
China-based Zai Lab and American pharmaceutical firm Pfizer have announced a strategic collaboration for the novel anti-...Read more
Pharma | News | 0 Comment | 24 Nov, 2024
Roche Pharmaceuticals has shared encouraging 16-week interim data from its ongoing phase 3b/4 SALWEEN trial, showing sig...Read more
Pharma | News | 0 Comment | 23 Nov, 2024
US-based Kura Oncology, Inc. and Japanese pharmaceutical firm Kyowa Kirin have entered into a global strategic collabora...Read more
South Korea approves Everest Medicines' NEFECON for treatment of Primary IgA Nephropathy
Pharma | News | 0 Comment | 23 Nov, 2024
China-based Everest Medicines has announced that NEFECON has received full approval from the Ministry of Food and Drug...Read more
Korea announces first-of-its-kind research agreement to discover radiopharmaceutical compounds
Pharma | News | 0 Comment | 19 Nov, 2024
SK Biopharmaceuticals, a biotech company in South Korea, has entered into an agreement with the Korea Institute of Radio...Read more
Lilly expands R&D footprint in Singapore with S$42 M investment in new Digital Health Innovation Hub
Pharma | News | 0 Comment | 14 Nov, 2024
Lilly Digital Health and Lilly Centre for Clinical Pharmacology (LCCP), a wholly owned subsidiary of U.S.-based Eli Lill...Read more
analytica Vietnam Expands for 2025 with Addition of New Hall
Pharma | News | 0 Comment | 12 Nov, 2024
• The largest edition yet, nearly double the size of the 2023 edition.• Hall A1 fully booked six months in adv...Read more